No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
HIBB240517C70000
- 17.15
- 0.000.00%
15min DelayTrading May 15 11:16 ET
0.00High0.00Low
0.00Open17.15Pre Close0 Volume0 Open Interest70.00Strike Price0.00Turnover1642.33%IV0.89%PremiumMay 17, 2024Expiry Date16.38Intrinsic Value100Multiplier-3DDays to Expiry0.77Time Value100Contract SizeAmericanOptions Type0.9558Delta0.0085Gamma5.04Leverage Ratio-22.2594Theta0.0000Rho4.81Eff Leverage0.0006Vega
Intraday
- 5D
- 1D
News
Investors Aren't Buying Hibbett, Inc.'s (NASDAQ:HIBB) Earnings
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 17x, you may consider Hibbett, Inc. (NASDAQ:HIBB) as an attractive investment with its 10x P/E ra
Hibbett Cut to Neutral From Outperform by Baird
Hibbett Cut to Neutral From Outperform by Baird
Hibbett Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/26/2024 2.33% Baird $80 → $87.5 Downgrades Outperform → Neutral 04/24/2024 2.33% B. Riley Securities $7
Baird Downgrades Hibbett to Neutral From Outperform, Price Target Is $87.50
Hibbett (HIBB) has an average rating of outperform and price targets ranging from $73 to $87.50, according to analysts polled by Capital IQ.
Maintaining Hold Rating Amid JD Sports' Proposed Acquisition of Hibbett Sports
Analysts Offer Insights on Consumer Cyclical Companies: Hibbett Sports (HIBB), NVR (NVR) and Packaging (PKG)
Comments
$Hibbett Sports(HIBB.US$ why it fell?
Morning Movers
Gapping up
$Madrigal Pharmaceuticals(MDGL.US$ stock jumped 25% after the U.S. Food and Drug Administration approved its drug for a fatty liver disease known as non-alcoholic steatohepatitis.
$Rivian Automotive(RIVN.US$ stock rose 3.9% after Piper Sandler upgraded its stance on the EV manufacturer to overweight, citing growing excitement surrounding new product launches.
Gapping down
$Adobe(ADBE.US$ stock f...
Gapping up
$Madrigal Pharmaceuticals(MDGL.US$ stock jumped 25% after the U.S. Food and Drug Administration approved its drug for a fatty liver disease known as non-alcoholic steatohepatitis.
$Rivian Automotive(RIVN.US$ stock rose 3.9% after Piper Sandler upgraded its stance on the EV manufacturer to overweight, citing growing excitement surrounding new product launches.
Gapping down
$Adobe(ADBE.US$ stock f...
27
Hibbett's Q4 results were disappointing with misses on revenue, EPS, and same-store sales. The company's full-year EPS guidance was also below expectations. Despite the challenging quarter, the company's CEO highlighted a solid financial performance and a record full fiscal year sales of $1.73 billion.
2
Hibbett's upward trend, especially a strong ROCE, signals promising future and potential successful reinvestment opportunities. High investor expectations for future performance suggest a growth trend worth further investigation.
While Hibbett, Inc. is trading below the industry PE ratio, it comes with the risk of an expected negative growth. For potential investors, it's recommended to research further into the stock considering these risks.
Read more